コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 and have been used as probiotics to prevent antibiotic associated diarrhea.
2 e to the high recurrence rates of nosocomial antibiotic-associated diarrhea.
3 Clostridium difficile is a leading cause of antibiotic-associated diarrhea.
4 e facilities and is the most common cause of antibiotic-associated diarrhea.
5 nosocomial pathogen and the leading cause of antibiotic-associated diarrhea.
6 ficile infection (CDI) is a leading cause of antibiotic-associated diarrhea.
7 ficile is an anaerobic bacterium that causes antibiotic-associated diarrhea.
8 (CPE) is a major cause of food poisoning and antibiotic-associated diarrhea.
9 phase of growth and are the leading cause of antibiotic-associated diarrhea.
10 ogical agent of pseudomembranous colitis and antibiotic-associated diarrhea.
11 erotoxin is a common cause of food-borne and antibiotic-associated diarrhea.
12 des difficile is the main causative agent of antibiotic-associated diarrhea.
13 rom acute infectious diarrhea and preventing antibiotic-associated diarrhea.
14 enterotoxin (CPE) causes food poisoning and antibiotic-associated diarrhea.
15 pathogenic bacterium and a leading cause of antibiotic-associated diarrhea.
16 rotoxin (CPE) cause human food poisoning and antibiotic-associated diarrhea.
17 ciated dysbiosis and adverse effects such as antibiotic-associated diarrhea.
18 are often considered in children to prevent antibiotic-associated diarrhea.
19 ifficile has emerged as the leading cause of antibiotic-associated diarrhea.
20 sociated infections and the leading cause of antibiotic-associated diarrhea.
21 ium innocuum may be an unrecognized cause of antibiotic-associated diarrhea (AAD) and clinically indi
22 is the most common cause of severe cases of antibiotic-associated diarrhea (AAD) and is a significan
25 umans, type A strains causing CPE-associated antibiotic-associated diarrhea (AAD) or sporadic diarrhe
26 probiotic formulations in the prevention of antibiotic-associated diarrhea (AAD) remains unclear.
27 in-treated rats, which significantly reduced antibiotic-associated diarrhea (AAD) resulting from the
28 represent a novel therapy to protect against antibiotic-associated diarrhea (AAD), C. difficile-assoc
32 ridium difficile is a major cause of chronic antibiotic-associated diarrhea and a significant health
34 ges and the capsules to reduce incidences of antibiotic-associated diarrhea and Clostridium difficile
35 the causative agent of primary and recurrent antibiotic-associated diarrhea and colitis in hospitaliz
37 toxin A, a potent enterotoxin that mediates antibiotic-associated diarrhea and colitis in humans.
38 rotoxin from Clostridium difficile, mediates antibiotic-associated diarrhea and colitis in humans.
41 tridioides difficile is the primary cause of antibiotic-associated diarrhea and colitis, a healthcare
42 le recently were isolated from patients with antibiotic-associated diarrhea and colitis, indicating t
43 to prevent and treat acute gastroenteritis, antibiotic-associated diarrhea and colitis, inflammatory
47 e is a nosocomial bacterial pathogen causing antibiotic-associated diarrhea and fatal pseudomembranou
48 at they may be a factor in diseases, such as antibiotic-associated diarrhea and gas gangrene, that ar
49 alth challenge as it is the leading cause of antibiotic-associated diarrhea and is associated with si
50 Clostridium difficile, a causative agent of antibiotic-associated diarrhea and its potentially letha
51 ogen C. difficile, the most serious cause of antibiotic-associated diarrhea and pseudomembranous coli
53 tt began trials investigating the problem of antibiotic-associated diarrhea and pseudomembranous coli
54 lostridium difficile is the leading cause of antibiotic-associated diarrhea and pseudomembranous coli
55 nd inflammation that manifests clinically as antibiotic-associated diarrhea and pseudomembranous coli
57 a nonpathogenic yeast that protects against antibiotic-associated diarrhea and recurrent Clostridium
58 e human gastrointestinal diseases, including antibiotic-associated diarrhea and sporadic diarrhea.
59 n gastrointestinal (GI) illnesses, including antibiotic-associated diarrhea and sporadic diarrhea.
60 icile causes approximately 25% of nosocomial antibiotic-associated diarrheas and most cases of pseudo
61 ridium difficile toxins A and B, which cause antibiotics-associated diarrhea and pseudomembranous col
63 tridial myonecrosis), enteritis necroticans, antibiotic-associated diarrhea, and acute food poisoning
64 cile infection (CDI) is the leading cause of antibiotic-associated diarrhea, and its clinical symptom
65 difficile is the leading cause of nosocomial antibiotic-associated diarrhea, and recent outbreaks of
66 eal disorders, including rotavirus diarrhea, antibiotic-associated diarrhea, Clostridium difficile di
68 estinal disorders, including viral diarrhea, antibiotic-associated diarrhea, Clostridium difficile-as
69 patients was based on clinical criteria for antibiotic-associated diarrhea combined with laboratory
71 se, irritable bowel syndrome, infectious and antibiotic-associated diarrhea, diabetes, nonalcoholic f
73 Clostridium difficile, the causal agent of antibiotic-associated diarrhea, has a complex epidemiolo
74 le, the major human pathogen responsible for antibiotic-associated diarrhea, has only a single functi
75 robiotics are associated with lower rates of antibiotic-associated diarrhea in children (aged 1 month
76 ifficile is one of the most common causes of antibiotic-associated diarrhea in developed countries.
77 lostridium difficile is the leading cause of antibiotic-associated diarrhea in hospitalized patients.
78 Clostridioides difficile, a major cause of antibiotic-associated diarrhea, is suppressed by the gut
79 fects of probiotics against the incidence of antibiotic-associated diarrhea of hospitalized patients
80 um difficile infection is a leading cause of antibiotic-associated diarrhea, placing considerable eco
82 n linked to significant side effects such as antibiotic-associated diarrhea, pseudomembranous colitis
83 medical conditions vary from infectious and antibiotic-associated diarrhea to obesity to chronic neu
84 f a probiotic associated with lower rates of antibiotic-associated diarrhea without an increase in cl
85 tridioides difficile is the leading cause of antibiotic-associated diarrhea worldwide with significan